| Trial ID: | L3851 |
| Source ID: | NCT01038895
|
| Associated Drug: |
Ramipril
|
| Title: |
Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Type 2 Diabetes
|
| Interventions: |
DRUG: Ramipril|DRUG: Experimental
|
| Outcome Measures: |
Primary: Antiproteinuric effect as well as antihypertensive effect of aliskiren 300 mg / daily versus ramipril 10 mg daily in hypertensive patients with type 2 diabetes and microalbuminuria., 3 months | Secondary: Average of 24 hours by ABPM, systolic and diastolic blood pressure, 3 months|Average daytime, systolic and diastolic blood pressure, 3 months|Average night, systolic and diastolic blood pressure, 3 months
|
| Sponsor/Collaborators: |
Sponsor: University of Pavia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2009-12-24
|
| Locations: |
University of Pavia, Pavia, PV, 27100, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT01038895
|
